XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Based Compensation - Narrative (Details) - $ / shares
3 Months Ended 12 Months Ended
Apr. 25, 2022
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Oct. 31, 2020
Stock-based compensation              
Common stock, shares issued   9,993,135   9,993,135      
Options granted (in shares)   265,000 73,669        
Options exercised (in shares)   0 0        
Minimum              
Stock-based compensation              
Stock awards vesting period   1 year          
Options granted, grant date fair value   $ 2.62 $ 5.40        
Maximum              
Stock-based compensation              
Stock awards vesting period   4 years          
Options granted, grant date fair value   $ 2.90 $ 6.14        
Stock options              
Stock-based compensation              
Options granted (in shares)   265,000          
Options exercised (in shares)   0          
Restricted Stock Units (RSUs) [Member]              
Stock-based compensation              
Restricted Stock Units, Granted   0   18,992 3,938 14,000  
Stock units forfeited         1,491    
Restricted Stock Units outstanding/unvested   18,992   18,992      
Restricted stock units, grant date fair value   $ 6.69   $ 6.69      
Restricted Stock Units (RSUs) [Member] | Fulfillment of Certain Clinical Conditions [Member]              
Stock-based compensation              
Restricted Stock Units outstanding/unvested         16,524    
Restricted Stock Units (RSUs) [Member] | Minimum              
Stock-based compensation              
Stock awards vesting period       1 year      
Restricted Stock Units (RSUs) [Member] | Maximum              
Stock-based compensation              
Stock awards vesting period       3 years      
2018 Equity Incentive Plan (the "2018 Plan") [Member]              
Stock-based compensation              
Number of shares reserved for issuance   260,794          
Life of stock option awards granted   10 years          
Number of authorized additional shares to be issued 500,000            
2018 Equity Incentive Plan (the "2018 Plan") [Member] | Minimum              
Stock-based compensation              
Stock awards vesting period   1 year          
2018 Equity Incentive Plan (the "2018 Plan") [Member] | Maximum              
Stock-based compensation              
Stock awards vesting period   4 years          
Inducement Equity Incentive Plan 2020 [Member]              
Stock-based compensation              
Number of shares reserved for issuance   80,000          
Number of authorized shares             200,000
Common stock, shares issued   120,000